Evidence map›Paper›PMID 34550810›Full record

ArticleJournal of clinical microbiology2021

A Systematic Evaluation of IgM and IgG Antibody Assay Accuracy in Diagnosing Acute Zika Virus Infection in Brazil: Lessons Relevant to Emerging Infections.

Raquel Medialdea-Carrera, Flavia Levy, Priscila Castanha, Patricia Carvalho de Sequeira, Patricia Brasil, Lia L Lewis-Ximenez, Lance Turtle, Tom Solomon, Ana Maria Bispo de Filippis, David W Brown and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Identification and characterization of a nonbiological small-molecular mimic of a Zika virus conformational neutralizing epitope.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Article
  6. Trends in ELISA-Based Flavivirus IgG Serosurveys: A Systematic Review.Tropical medicine and infectious disease · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Raquel Medialdea-CarreraNational Institute for Health Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections (HPRU EZI), Institute of Infection and Global Health, University of Liverpoolgrid.10025.36, Liverpool, UK.ORCID 0000-0002-0371-5138
Flavia LevyFlavivirus Reference Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
Priscila CastanhaAggeu Magalhães Research Center, Oswaldo Cruz Foundation (FIOCRUZ), Recife, Pernambuco, Brazil.ORCID 0000-0002-1220-5308
Patricia Carvalho de SequeiraFlavivirus Reference Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
Patricia BrasilEvandro Chagas National Institute of Infectious Diseases; Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.
Lia L Lewis-XimenezViral Hepatitis Clinic, Viral Hepatitis National Reference Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
Lance TurtleNational Institute for Health Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections (HPRU EZI), Institute of Infection and Global Health, University of Liverpoolgrid.10025.36, Liverpool, UK.
Tom SolomonNational Institute for Health Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections (HPRU EZI), Institute of Infection and Global Health, University of Liverpoolgrid.10025.36, Liverpool, UK.
Ana Maria Bispo de FilippisFlavivirus Reference Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
David W Brown *Flavivirus Reference Laboratory, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
Michael J Griffiths *National Institute for Health Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections (HPRU EZI), Institute of Infection and Global Health, University of Liverpoolgrid.10025.36, Liverpool, UK.ORCID 0000-0003-1851-6155
Fundação Oswaldo Cruz · BRUniversity of Liverpool · GBHospital Universitário Oswaldo Cruz · BRPublic Health England · GB

Funding

Department of Health NIHR200907European Research Council 734584European Research Council 734857Medical Research Council MC_PC_15101Wellcome TrustWellcome Trust 205228/Z/16/Z
6 · The paper itself

Abstract

Accurate diagnostics underpin effective public health responses to emerging viruses. For viruses, such as Zika virus (ZIKV), where the viremia clears quickly, antibody-based (IgM or IgG) diagnostics are recommended for patients who present 7 days after symptom onset. However, cross-reactive antibody responses can complicate test interpretation among populations where closely related viruses circulate. We examined the accuracy (proportion of samples correctly categorized as Zika positive or negative) for antibody-based diagnostics among Brazilian residents (Rio de Janeiro) during the ZIKV outbreak. Four ZIKV enzyme-linked immunosorbent assays (ELISAs; IgM and IgG Euroimmun, IgM Novagnost, and CDC MAC), two dengue ELISAs (IgM and IgG Panbio), and the ZIKV plaque reduction neutralization test (PRNT) were evaluated. Positive samples were ZIKV PCR confirmed clinical cases collected in 2015-2016 (

Indexed as

Zika VirusZika Virus InfectionAntibodies, ViralBrazilEnzyme-Linked Immunosorbent AssayHumansImmunoglobulin GImmunoglobulin MSerologic TestsAntibodies, ViralImmunoglobulin GImmunoglobulin Mdiagnosisimmunoassaysplaque reduction neutralization tests (PRNTs)serologyserology evaluationZika antibody assaysZika virus

Identifiers

PMID34550810
PMCPMC8601218
OpenAlexW3199742661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.